Butterfly Network, Inc. (BFLY)
NYSE · Healthcare · Medical Devices
$9.38+4.80%as of Oct 6, 2026, 1:35 AM ET
- Market cap
- $2.5B
- 52-week range
- $1.90 – $10.05
- 52-week change
- +249.61%
- EPS (trailing)
- −$0.29
- Analyst rating
- 1.2 Strong buy
- Next earnings
- Oct 30, 2026
Fiscal year to Dec 2025
- Revenue
- $97.6M (+18.96%)
- Net income
- −$77.1M
- Operating margin
- −88.5%
- Diluted EPS
- −$0.31
- Free cash flow
- −$16.1M
From the company’s annual report on SEC EDGAR.
About Butterfly Network, Inc.
Butterfly Network, Inc. develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally. The company offers Butterfly iQ+ and iQ3 ultrasound devices that can perform whole-body imaging on a single handheld probe integrated with the clinical workflow, and accessible on a user's smartphone, tablet, and almost any hospital computer system; Butterfly Move, merging the mobility of a handheld with the stability of a full cart system; and iQ+ Bladder, a specialty product for bladder scanning market. It also provides Compass AI which offers one system to connect every device, workflow, and department; ScanLab, an AI-powered educational platform that provides written walkthroughs and reference imagery to guide real-time educational scanning; and Butterfly iQ+/iQ3 Vet, a third generation handheld ultrasound system. It sells and markets its products through a direct sales force, distributors, and e-commerce channels. Butterfly Network, Inc. was founded in 2011 and is headquartered in Burlington, Massachusetts.
Headquarters: Burlington, United States · 220 employees · butterflynetwork.com